Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers Diana Beatriz BayaniYihao Clement LinHwee Lin Wee Original Research Article Open access 20 June 2024
Cost-Effectiveness of Vedolizumab as a First-Line Advanced Therapy Versus Adalimumab Treatment Sequences for Ulcerative Colitis in Italy Jonathan SalcedoDaniel Hill-McManusGennaro Di Martino Original Research Article Open access 11 June 2024
Correction: NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances Dawn LeeDarren BurnsEd Wilson Correction Open access 05 June 2024
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina Carlos Rojas-RoqueConstanza SilvestriniNatalia Espinola Original Research Article Open access 03 June 2024
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France Gérard de PouvourvilleManon Breau-BrunelCéline Pribil Original Research Article Open access 23 May 2024
Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature Review Vittoria ArditoLudovico CavallaroOriana Ciani Protocol Open access 21 May 2024
Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country Najmeh MoradiLeila ZareiKamran Bagheri Lankarani Original Research Article Open access 18 May 2024
Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension Rod S. TaylorAnthony BentleyRoland E. Schmieder Correction Open access 08 May 2024
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs Micha J. PilzSimone Seyringerthe EORTC Quality of Life Group Original Research Article Open access 02 May 2024
Whither Decision-Analytic Modelling-Based Economic Evaluation for Health Care Decision Making? Rachael Maree HunterMatthew Franklin Editorial Open access 25 April 2024
Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model Emma McManus Original Research Article Open access 20 April 2024
Cost of Care for Non-communicable Diseases: Which Types of Healthcare Providers are the Most Economical in India’s Chhattisgarh State? Samir GargNarayan TripathiKirtti Kumar Bebarta Original Research Article Open access 17 April 2024
NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances Dawn LeeDarren BurnsEd Wilson Editorial Open access 13 April 2024
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older Sydney GeorgeJustin CarricoNikolaos Giannelos Original Research Article Open access 11 April 2024 Pages: 481 - 492
Behind the Scenes: A Qualitative Investigation of Interviewers' Performance in EQ-5D Valuation Studies Carlotta VarrialeGiovanni AndrulliAureliano Paolo Finch Original Research Article Open access 09 April 2024 Pages: 389 - 401
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus Olga PitsillidouPanagiotis PetrouM. J. Postma Original Research Article Open access 04 April 2024 Pages: 471 - 480
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol Shahzad GhanbarianGavin W. K. WongStirling Bryan Protocol Open access 26 March 2024 Pages: 493 - 505
Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany Niklaus MeierHendrik FuchsMatthias Schwenkglenks Original Research Article Open access 23 March 2024 Pages: 373 - 387
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Sudewi Mukaromah KhoirunnisaFithria Dyah Ayu SuryanegaraMaarten Jacobus Postma Systematic Review Open access 15 March 2024
Identification and prioritisation of items for a draft participant-reported questionnaire to measure use of social care, informal care, aids and adaptations Kirsty M. GarfieldGail A. ThorntonJoanna C. Thorn Original Research Article Open access 07 March 2024 Pages: 431 - 443
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales Colin BurkeCatriona CrossanSally Bowditch Original Research Article Open access 05 March 2024
Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis Christian BührerThomas PalingMarloes Bagijn Original Research Article Open access 04 March 2024 Pages: 445 - 457
Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease Syed G. MohiuddinMary E. WardHoward H. Z. Thom Systematic Review Open access 23 February 2024 Pages: 359 - 371
Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Elvio Emanuele RossiniCarlotta GaleoneClaudio Jommi Correction Open access 12 February 2024 Pages: 345 - 345
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models Tim ReasonEmma BenbowBill Malcolm Original Research Article Open access 10 February 2024 Pages: 205 - 220
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models Tim ReasonWilliam RawlinsonSven Klijn Original Research Article Open access 10 February 2024 Pages: 191 - 203
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension Rod S. TaylorAnthony BentleyRoland E. Schmieder Original Research Article Open access 30 January 2024
Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review Malvina HoxhaVisar MalajBruno Zappacosta Systematic Review Open access 27 January 2024 Pages: 147 - 170
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population Joe W. E. MossDerick ToddPrapa Kanagaratnam Original Research Article Open access 20 January 2024 Pages: 417 - 429
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain Rosa María Romero JiménezPedro Herranz PintoFrancisco José Rebollo Laserna Original Research Article Open access 18 January 2024 Pages: 291 - 302
Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil Henrique Lima CoutoLudmila Peres GarganoFernando Zanghelini Original Research Article Open access 18 January 2024 Pages: 403 - 416
Introducing Open Science in Teaching Health Economic Modelling Xavier G. L. V. PouwelsHendrik Koffijberg Practical Application Open access 18 January 2024 Pages: 347 - 357
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Elvio Emanuele RossiniCarlotta GaleoneClaudio Jommi Original Research Article Open access 16 January 2024 Pages: 251 - 261
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma Fei Fei LiuMeaghan BartlettSamantha Craigie Systematic Review Open access 10 January 2024 Pages: 171 - 190
Health-Related Quality of Life and Economic Burden Among Hospitalized Children with Hand, Foot, and Mouth Disease: A Multiregional Study in China Ting ZhouHongfei HuPei Wang Original Research Article Open access 09 January 2024 Pages: 459 - 469
Health State Utilities Associated with False-Positive Cancer Screening Results Louis S. MatzaTimothy A. HowellKaren C. Chung Original Research Article Open access 08 January 2024 Pages: 263 - 276
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study Andrew J. GoldbergEkaterina Bordeathe TARVA Study Group Original Research Article Open access 08 January 2024 Pages: 235 - 249
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies Ankita KaushikGeoffrey DusheikoRobert J. Wong Original Research Article Open access 03 January 2024 Pages: 333 - 343
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark Milanne Maria Johanna GalekopCarin Uyl-de GrootWilliam Ken Redekop Original Research Article Open access 19 December 2023 Pages: 313 - 331
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals Jose Luis CallejaJaime EspinAdam Igloi-Nagy Original Research Article Open access 15 December 2023 Pages: 221 - 233
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain Bérengère MacabeoThéophile RotrouPhilippe Laramée Original Research Article Open access 14 December 2023 Pages: 5 - 18
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden Maria PolyzoiMattias EkmanRobert Hettle Original Research Article Open access 13 December 2023 Pages: 277 - 289
An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund Laura A. TriggMaxwell S. BarnishCaroline Farmer Original Research Article Open access 12 December 2023 Pages: 303 - 311
United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument Madeleine T. KingD. A. Revickithe MAUCa Consortium Original Research Article Open access 07 December 2023 Pages: 49 - 63
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15 Marty ChaplinRebecca BresnahanPinki Munot Correction Open access 05 December 2023 Pages: 1015 - 1015
Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis Joost G. E. VerbeekKaren van der SluisValesca P. Retèl Original Research Article Open access 30 November 2023 Pages: 119 - 131
Developing a Natural History Model for Duchenne Muscular Dystrophy Jonathan BroomfieldM. HillProject HERCULES, the Cooperative International Neuromuscular Research Group investigators, Duchenne Regulatory Science Consortium members Original Research Article Open access 29 November 2023 Pages: 79 - 89
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland Andrea Favre-BulleMin HuangArjun Bhadhuri Original Research Article Open access 24 November 2023 Pages: 91 - 101
Preferences for Living Arrangements in Dementia: A Discrete Choice Experiment Christian SpeckemeierCarina AbelsSilke Neusser Original Research Article Open access 23 November 2023 Pages: 65 - 78